These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 17892157

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Development of new concepts in vaccines and their effects on the control of infectious diseases (classical swine fever in particular).
    Vannier P.
    Dev Biol (Basel); 2004; 119():235-41. PubMed ID: 15742634
    [Abstract] [Full Text] [Related]

  • 3. The place of marker vaccines in control and eradication of animal diseases--aspects of comparative interest.
    Pastoret PP.
    Dev Biol (Basel); 2005; 121():181-8. PubMed ID: 15962481
    [Abstract] [Full Text] [Related]

  • 4. Eradication versus vaccination strategies to control infectious diseases--some lessons to be learned from terrestrial animals.
    Moennig V.
    Dev Biol (Basel); 2005; 121():13-9. PubMed ID: 15962466
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Overview of marker vaccine and differential diagnostic test technology.
    Henderson LM.
    Biologicals; 2005 Dec; 33(4):203-9. PubMed ID: 16257545
    [Abstract] [Full Text] [Related]

  • 8. Regulatory considerations for marker vaccines and diagnostic tests in the U.S.
    Foley PL, Hill RE.
    Biologicals; 2005 Dec; 33(4):253-6. PubMed ID: 16257538
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Regulatory considerations for emergency use of vaccines in the European Union.
    Pastoret PP, Mackay D.
    Dev Biol (Basel); 2003 Dec; 114():53-8. PubMed ID: 14677676
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Biotechnology for the benefit of vaccination against viral diseases: a review].
    van Oirschot JT.
    Tijdschr Diergeneeskd; 2002 Jan 01; 127(1):7-16. PubMed ID: 11795035
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Novel marker vaccines against classical swine fever.
    Beer M, Reimann I, Hoffmann B, Depner K.
    Vaccine; 2007 Jul 26; 25(30):5665-70. PubMed ID: 17239502
    [Abstract] [Full Text] [Related]

  • 17. New approaches to animal vaccines utilizing genetic engineering.
    Devaney MA.
    Crit Rev Microbiol; 1988 Jul 26; 15(3):269-95. PubMed ID: 2837363
    [Abstract] [Full Text] [Related]

  • 18. Novel vaccines from biotechnology.
    Rogan D, Babiuk LA.
    Rev Sci Tech; 2005 Apr 26; 24(1):159-74. PubMed ID: 16110886
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Foot-and-mouth disease:: an old disease--new solutions].
    Pastoret PP.
    Bull Mem Acad R Med Belg; 2005 Apr 26; 160(1-2):103-8; discussion 108. PubMed ID: 16116814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.